Matthew W Foehr - Net Worth and Insider Trading

Over the past 18 months, Matthew W Foehr made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 16,812 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .

In summary, during the past 3 months, insiders sold 4,510 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 4,510 shares. During the past 18 months, 106,293 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,793 shares.

Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew W Foehr made no insider transaction in Viking Therapeutics Inc (VKTX). Other recent insider transactions involving Viking Therapeutics Inc (VKTX) include a net sale of 879,938 shares made by Brian Lian , a net sale of 68,786 shares made by J Matthew Singleton , and a net sale of 229,579 shares made by Greg Zante .

In summary, during the past 3 months, insiders sold 160,687 shares of Viking Therapeutics Inc (VKTX) in total and bought 0 shares, with a net sale of 160,687 shares. During the past 18 months, 1,545,754 shares of Viking Therapeutics Inc (VKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,545,754 shares.

Viking Therapeutics Inc (VKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ritter Pharmaceuticals Inc (RTTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ritter Pharmaceuticals Inc (RTTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ritter Pharmaceuticals Inc (RTTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Qualigen Therapeutics Inc (QLGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Qualigen Therapeutics Inc (QLGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Qualigen Therapeutics Inc (QLGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Avista Public Acquisition Corp II (AHPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avista Public Acquisition Corp II (AHPA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Avista Public Acquisition Corp II (AHPA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew W Foehr made 6 insider transaction in OmniAb Inc (OABI) with a net purchase of 791,366. Other recent insider transactions involving OmniAb Inc (OABI) include a net sale of 42,674 shares made by Kurt A Gustafson , a net sale of 14,976 shares made by Charles S Berkman ,

In summary, during the past 3 months, insiders sold 45,527 shares of OmniAb Inc (OABI) in total and bought 0 shares, with a net sale of 45,527 shares. During the past 18 months, 71,284 shares of OmniAb Inc (OABI) were sold and 805,000 shares were bought by its insiders, resulting in a net purchase of 733,716 shares.

OmniAb Inc (OABI)'s detailed insider trading history can be found in Insider Trading Tracker table.